September 10, 2025 – Altstätten, Switzerland – We are proud to share that icotec AG has been awarded the SEF.Growth High Potential Label by the Swiss Economic Forum.
Clearer images. Earlier detection. Better outcomes.
icotec AG is redefining spine cancer treatment with its BlackArmor® implants – radiolucent, carbon-based implants that let doctors see what metal hides. By making CT and MRI scans fully visible, icotec enables more precise radiation planning and earlier tumor detection, giving patients safer and more effective care.
What convinced the SEF.Growth experts?
A rare combination of proprietary technology, strong clinical evidence, and a clear global growth strategy. With over 20,000 patients treated, inclusion in U.S. and German guidelines, and partnerships with world-class institutions, icotec is setting a new standard in spine care.
About icotec ag
icotec is the leading company for the treatment of spinal tumors and spinal infections with a new generation of high-tech implants. With its BlackArmor® Carbon/PEEK implant, icotec combines cutting-edge technologies and industry expertise to deliver innovative and reliable solutions for spine surgeons and their patients and is dedicated to advancing the field of spinal implantation. With a track record of clinical success and a commitment to continuous innovation, icotec is poised to shape the future of spinal surgery. The comprehensive product portfolio has received FDA clearance and is supported by numerous Key Opinion Leaders and Cancer Therapy Centers worldwide. More information can be found at www.icotec-medical.com.
Contact
For more information or questions, please contact hello@icotec-medical.com.